Hikma Pharmaceutical | HIK - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Almirall EUR 324.81M 61.32M 2025-12
argenx SE USD 35.57M 3.05M 2025-06
AstraZeneca USD 25.96B 177M 2026-03
Autolus Therapeutics Ltd USD 277.27M 7.07M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
Fresenius EUR 9.22B 1.58B 2025-12
Genmab DKK 5.14B 5.01B 2025-12
GlaxoSmithKline GBP 14.01B 696M 2026-03
GRIFOLS EUR 9.08B 612M 2026-03
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lakefront Biotherapeutics EUR 4.85M 335K 2026-03
Lonza CHF 3.88B 323M 2025-12
Merck EUR 10.8B 72M 2026-03
Orion EUR 110.6M 4.7M 2026-03
Recordati EUR 1.76B 373.2M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
UCB EUR 2.18B 634M 2025-12